ERBB2 and cancer: The greater SH2 recruitment capacity of ErbB1 and ErbB2 was hypothesized to confer greater oncogenic potential to cancer cells than ErbB3 and ErbB4 given that many SH2 domains are contained in proteins that facilitate mitogenesis, cell survival, and cell motility [34].